Studien: COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment-II (COMFORT-II)ID StudieINCB 18424-352EudraCT-Nummer2009-009858-24Clinicaltrials.gov IdentifierNCT00934544BeschreibungA Randomized Study of the JAK Inhibitor INCB018424 Tablets Compared to Best Available Therapy in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) StatusgeschlossenErkrankung
SponsorKeine DatenStudienleiterKeine DatenHauptprüfer
Studienassistent
|
|